Skip to main content
News Mass 12.2021
© Volker Lannert / Uni Bonn

News categories: Honors & Funding

Elvira Mass selected as EMBO Young Investigator junior scientist

Prof. Elvira Mass, developmental biologist at the LIMES Institute of the University of Bonn and member of the Cluster of Excellence ImmunoSensation2, will join the EMBO Young Investigator Program on 01.01.2022.

The EMBO Young Investigator Program supports selected young European scientists with outstanding achievements in the field of life sciences. The award is linked to a financial support of 15,000 €, which can be extended by up to 10,000 € per year. Prof. Elvira Mass and her team study the development and function of resident macrophages - phagocytes that are present in almost every tissue and, as part of the innate immune system, are an important part of the body's defense system.

Macrophages form the first line of defense against pathogens by ingesting them and breaking them down into their components (antigens). They present these antigens to other cells of the immune system and produce cytokines, which elicits an adapted immune response. According to recent scientific findings, however, resident macrophages have more tasks than previously thought: Beyond their classical role as scavenger cells, resident macrophages most likely significantly contribute to organ development. The team led by Prof. Elvira Mass investigates the function of resident macrophages in brain development. For this purpose, she recently received an ERC Starting Grant to investigate potential hazards of nanoplastics ingested with the food. The aim is to clarify whether the nanoplastic reaches our organs, whether it is taken up there, especially by macrophages, and whether it can induce or contribute to the development of neurological diseases in the long term (read more) .

However, the paradigm shift in the field of resident macrophages does not only apply to the function, but also to the origin of the phagocytes. Resident macrophages have been shown to develop in many organs during embryonic development and to self-renew in adult tissues under homeostatic conditions. Prof. Elvira Mass's team is interested in understanding the contribution of resident macrophages to homeostatic function during organ development, but also in the process of various disease conditions such as obesity or infectious diseases.

Born in present-day Kazakhstan, the Russian-German earned her PhD in Molecular Biomedicine at the University of Bonn, Germany, and returned to her alma mater after a three-year research stay at King's College London and Memorial Sloan-Kettering Cancer Center in New York. In 2017, she started the research group Developmental Biology of the Innate Immune System at LIMES Institute. In 2019, Elvira Mass was appointed W2 Professor at the University of Erlangen-Nürnberg, but was reappointed to the University of Bonn in 2020.

The scientific environment at the LIMES Institute and the Cluster of Excellence ImmunoSensation2 at the University of Bonn offers Prof. Elvira Mass an optimal environment for her research. This is based on the common scientific focus of the researchers at LIMES and other institutes united in the Cluster of Excellence ImmunoSensation2, as well as the connection to several national international research networks. With the EMBO Young Investigator award, this environment is now extended by a renowned network. In addition to direct financial support, Prof. Elvira Mass and her team will also benefit from training and mentoring opportunities linked to the award over the next 4 years.


Contact

Prof. Dr. Elvira Mass

Life & Medical Sciences Institute (Limes)

University of Bonn

Carl-Troll-Strasse 31

53115 Bonn

emass(at)uni-bonn.de

Related news

Kerstin Ludwig

News categories: Honors & Funding

Genome data to improve diagnosis and treatment of long Covid

Despite the many advances, there are still major gaps in the care of patients with long-term and post-COVID. The Institute of Human Genetics at the UKB in Bonn now begins a genomLC study as part of a BMG funding priority. The researchers want to help speed up the diagnosis of long- and post-COVID and identify possible biomarkers that could possibly also differentiate between subgroups of the diseases. To this end, the genomic data of those affected is being analyzed as part of a study using blood samples. The project is funded by the Federal Ministry of Health (BMG) with 1.34 million euros.
View entry
Reckzeh News

News categories: Honors & Funding

Creating Personalized Cancer Treatments

Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry
Prof. Dr. Valentin Schäfer

News categories: Honors & Funding

Valentin Schäfer appointed to Specialized Ethics Committee

Prof. Valentin S. Schäfer, Head of the Section of Rheumatology at the University Hospital Bonn (UKB) and researcher at the University of Bonn, has been appointed to the newly created Specialized Ethics Committee for Special Procedures by State Secretary Dr. Thomas Steffen at the Federal Ministry of Health. The committee, which is based at the Federal Institute for Drugs and Medical Devices (BfArM), will begin its work on July 1, 2025 and is responsible for the ethical evaluation of complex clinical trials.
View entry

Back to the news overview